Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
𝛼
SK
or Search
SIGN UP
SIGN IN
ENTITY
Mayne Pharma (MYX AU)
Watchlist
224
Analysis
Health Care
•
Australia
Mayne Pharma Group Ltd. develops and manufactures oral pharmaceuticals. The Company produces branded generics, specialty generics, and active pharmaceutical ingredients.
more
Watchlist
All
Insights
Primers
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bullish
•
Lynas Corp Ltd
•
02 Feb 2026 06:15
Aussie Shorts (23rd Jan 2026): Lynas, Light & Wonder, Domino's Pizza, Amcor, Boss Energy
Companies mentioned in this (soon-to-be-regular) weekly report include Lynas Corp (LYC AU), Light & Wonder (LNW US), Domino's Pizza Enterprises...
David Blennerhassett
Follow
470 Views
Share
bearish
•
IFBH
•
18 Dec 2025 10:07
IFBH IPO Lockup - US$262m Lockup Release but the Stock Has Nosedived
IFBH Ltd raised around US$169m from its Hong Kong IPO in June 2025. The lockup on its cornerstone and pre-IPO investors is set to expire soon.
Akshat Shah
Follow
554 Views
Share
bullish
•
Qube Holdings
•
01 Dec 2025 06:15
(Mostly) Asia M&A, Nov 2025 Wrap: Qube, Forum Engineering, National Storage REIT, Star Micronics
For the month of November, 8 new deals were discussed on Smartkarma with an overall deal size of ~US$10bn. The average premium for the new deals...
David Blennerhassett
Follow
511 Views
Share
bullish
•
Mandom Corp
•
30 Nov 2025 06:15
Asia-Pac M&A Weekly Wrap: Mandom, Monash IVF, National Storage REIT, Iress, Digital Holdings, Grindr
This insight provides a summary of gross/annualised spreads (on deals discussed on Smartkarma) across Asia-Pacific as at the last trading date, and...
David Blennerhassett
Follow
546 Views
Share
bullish
•
3SBio
•
23 Nov 2025 06:30
Last Week In Event SPACE: 3SBio/Mandi, CATL, Grindr, Mandarin Oriental
It’s Sunday! Pour yourself a coffee, grab a comfortable seat, and sift through a brief summary of insights on various events discussed during the...
David Blennerhassett
Follow
543 Views
Share
First
Previous
3
4
5
6
7
8
9
Next
Last
For Institutional Investors and Financial Services
For Corporate IR and Strategy
For Private Wealth Intermediaries
Pricing
How Smartkarma Compares
Who We Are
Careers
FAQs
Research Provider Solutions
Syndicate your Publications
Compliance
Terms of Use
Privacy Policy
Press Kit
RSS Feeds
Request a Free Trial
Avail a Transition Account
Guest Posts on Smartkarma
Other Enquiries
Join TL;DR Community
Free Weekly Newsletters
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.70.4
x